The chemokine ligand (CCL) 22 produced by macrophages and tumor cells can bind to chemokine receptor (CCR) 4 expressed on Tregs, consequently recruiting Treg into TME and leading to tumor growth and poor patients’ outcomes with its immunosuppressive function [37]. Here, CCR4 is linked to neoplasm.